ACRV: Miller Mary sold $585 of stock
By AlphaYouPublished Form 4
Miller Mary
Reporting filer
Miller Mary reported selling 294 shares of Acrivon Therapeutics, Inc. for about $585 ($1.99 a share on average). Form 4 filed Oct 7, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 7, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Miller Mary | 2026-10-05 | S | Sale | 294 | 1.99 | 81,715 | 2 days | Filed terms
|
Common Stock
- Owner
- Miller Mary
- Date
- 2026-10-05
- Code
- S
- Action
- Sale
- Quantity
- 294
- Price
- 1.99
- Following holdings
- 81,715
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-05
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 294
- transaction Price Per Share: 1.99
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 81715
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Miller Mary: Chief Legal Officer.
- F1: Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
- F2: The price reported in Column 4 above reflects the weighted average price of 337 shares sold by a broker on October 5, 2026, to satisfy the payment of withholding tax liability of a group of employees of the Issuer, including the reporting person. The proceeds of all such sales were allocated to the employees, including the reporting person, on a pro rata basis.
Original sources
Prepared automatically from public filing data. Report a correction.